Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis

American Journal of Obstetrics and Gynecology

Volumn 221, Issue 1, 2019, Pages 19-29.e3

  Sultan, Pervez ^a   Bampoe, Sohail ^a   Shah, Raj ^a   Guo, Nan ^b   Estes, Jaclyn ^b   Stave, Christopher ^b   Goodnough, Lawrence Tim ^b   Halpern, Stephen ^c   Butwick, Alex James ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

anemia; iron; postpartum period

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; FERROUS ASCORBATE; FERROUS FUMARATE; FERROUS SULFATE; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON PROTEIN SUCCINYLATE; IRON SACCHARATE; ANTIANEMIC AGENT; FERRIC ION; FERROUS ION;

ANAPHYLAXIS; ANEMIA; CONSTIPATION; DRUG SAFETY; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTRANSAMINASEMIA; INFECTION; IRON THERAPY; META ANALYSIS; MUSCLE CRAMP; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PUERPERIUM; RASH; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; URTICARIA; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; METABOLISM; ORAL DRUG ADMINISTRATION; PREGNANCY; PUERPERAL DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HEMATINICS; HEMOGLOBINS; HUMANS; IRON; PREGNANCY; PUERPERAL DISORDERS; TREATMENT OUTCOME;

EID: 85061248609     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2018.12.016     Document Type: Review

References (70)

1. Gaynes, B.N., Gavin, N., Meltzer-Brody, S., et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 119 (2005), 1–8.
2. Corwin, E.J., Murray-Kolb, L.E., Beard, J.L., Low hemoglobin level is a risk factor for postpartum depression. J Nutr 133 (2003), 4139–4142.
3. Lee, K.A., Zaffke, M.E., Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs 28 (1999), 183–191.
4. Beard, J., Hendricks, M., Perez, E., et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 135 (2005), 267–272.
5. Murray-Kolb, L.E., Beard, J.L., Iron deficiency and child and maternal health. Am J Clin Nutr 89 (2009), 946s–950s.
6. Milman, N., Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol 90 (2011), 1247–1253.
7. Butwick, A.J., Walsh, E.M., Kuzniewicz, M., Li, S.X., Escobar, G.J., Patterns and predictors of severe postpartum anemia after cesarean section. Transfusion 57 (2017), 36–44.
8. Wagner, K.S., Ronsmans, C., Thomas, S.L., et al. Women who experience obstetric haemorrhage are at higher risk of anaemia, in both rich and poor countries. Trop Med Int Health 17 (2012), 9–22.
9. Milman, N., Postpartum anemia II: prevention and treatment. Ann Hematol 91 (2012), 143–154.
10. World Health Organization. WHO Guideline: Iron supplementation in postpartum women. 2016, World Health Organization, Geneva Available at: http://apps.who.int/iris/handle/10665/249242. (Accessed 15 August 2018)
11. Munoz, M., Pena-Rosas, J.P., Robinson, S., et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med 28 (2018), 22–39.
12. Friedman, A.J., Shander, A., Martin, S.R., et al. Iron deficiency anemia in women: a practical guide to detection, diagnosis, and treatment. Obstet Gynecol Surv 70 (2015), 342–353.
13. Peyrin-Biroulet, L., Williet, N., Cacoub, P., Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 102 (2015), 1585–1594.
14. Moretti, D., Goede, J.S., Zeder, C., et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 126 (2015), 1981–1989.
15. Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., Gafter-Gvili, A., The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90 (2015), 12–23.
16. Lopez, A., Cacoub, P., Macdougall, I.C., Peyrin-Biroulet, L., Iron deficiency anaemia. Lancet 387 (2016), 907–916.
17. Markova, V., Norgaard, A., Jorgensen, K.J., Langhoff-Roos, J., Treatment for women with postpartum iron deficiency anaemia. Cochrane Database Syst Rev, 2015, CD010861.
18. Van Wyck, D.B., Martens, M.G., Seid, M.H., Baker, J.B., Mangione, A., Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 110 (2007), 267–278.
19. Damineni, S., Thunga, S., IV ferric carboxymaltose vs oral iron in the treatment of post-partum iron deficiency anaemia. J Clin Diag Res 10 (2016), QC08–QC10.
20. El Khouly, N.I., Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia. J Matern Fetal Neonatal Med 30 (2017), 967–971.
21. Holm, C., Thomsen, L., Norgaard, A., Langhoff-Roos, J., Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sang 112 (2017), 219–228.
22. Rathod, S., Samal, S.K., Mahapatra, P.C., Samal, S., Ferric carboxymaltose: a revolution in the treatment of postpartum anemia in Indian women. Int J Appl Basic Med Res 5 (2015), 25–30.
23. Garner, P., Hopewell, S., Chandler, J., et al. When and how to update systematic reviews: consensus and checklist. BMJ, 354, 2016, i3507.
24. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg 8 (2010), 336–341.
25. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recommend Rep 47 (1998), 1–29.
26. Bodnar, L.M., Scanlon, K.S., Freedman, D.S., Siega-Riz, A.M., Cogswell, M.E., High prevalence of postpartum anemia among low-income women in the United States. Am J Obstet Gynecol 185 (2001), 438–443.
27. Bodnar, L.M., Siega-Riz, A.M., Miller, W.C., Cogswell, M.E., McDonald, T., Who should be screened for postpartum anemia? An evaluation of current recommendations. Am J Epidemiol 156 (2002), 903–912.
28. Ouzzani, M., Hammady, H., Fedorowicz, Z., Elmagarmid, A., Rayyan─a Web and mobile app for systematic reviews. Syst Rev, 5, 2016, 210.
29. Goodnough, L.T., Shander, A., Patient blood management. Anesthesiology 116 (2012), 1367–1376.
30. Higgins, J.P.T., Altman, D.G., Sterne, J.A.C., Cochrane handbook for systematic reviews of interventions vsn 5.1.0. Cochrane Colloboration, 2011. Available at: https://training.cochrane.org/handbook. (Accessed 18 August 2018)
31. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
32. Bhandal, N., Russell, R., Intravenous vs oral iron therapy for postpartum anaemia. Br J Obstet Gynecol 113 (2006), 1248–1252.
33. Westad, S., Backe, B., Salvesen, K., et al. A 12-week randomised study comparing intravenous iron sucrose vs oral ferrous sulphate for treatment of postpartum anemia. Acta Obst Gynecol Scand 87 (2008), 916–923.
34. Verma, S., Inamdar, S., Malhotra, N., Intravenous iron therapy vs oral iron in postpartum patients in rural area. J S Asian Fed Obstet Gynaecol 3 (2011), 67–70.
35. Giannoulis, C., Daniilidis, A., Tantanasis, T., Dinas, K., Tzafettas, J., Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia 13 (2009), 38–40.
36. Guerra, M.S., Lopez, P.A., Munoz, H.H., Marin, M.J., Lete, L.I., Aizpuru, B.F., Randomized clinical trial to evaluate the effectiveness of two routes of iron administration, oral and intravenous, in the treatment of postpartum iron deficiency anemia. Clin Invest Gina Obst 39 (2012), 190–195.
37. Daniilidis, A., Giannoulis, C., Pantelis, A., Tantanasis, T., Dinas, K., Total infusion of low molecular weight iron-dextran for treating postpartum anemia. Clin Exp Obstet Gynecol 38 (2011), 159–161.
38. Jain, G., Palaria, U., Jha, S., Intravenous iron in postpartum anemia. J Obst Gynaecol India 63 (2013), 45–48.
39. Seid, M.H., Derman, R.J., Baker, J.B., Banach, W., Goldberg, C., Rogers, R., Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 199 (2008), 435.e1–435.e7.
40. Breymann, C., Gliga, F., Bejenariu, C., Strizhova, N., Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 101 (2008), 67–73.
41. Mumtaz, A., Farooq, F., Comparison for effects of intravenous vs oral iron therapy for postpartum anemia. Pak J Med Health Sci 5 (2011), 116–120.
42. Pollock, R.F., Muduma, G., A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000. Clinicoecon Outcomes Res 9 (2017), 475–483.
43. Blanton, C.A., Green, M.W., Kretsch, M.J., Body iron is associated with cognitive executive planning function in college women. Br J Nutr 109 (2013), 906–913.
44. Scott, S.P., Murray-Kolb, L.E., Iron status is associated with performance on executive functioning tasks in nonanemic young women. J Nutr 146 (2016), 30–37.
45. Troy, N.W., Is the significance of postpartum fatigue being overlooked in the lives of women?. MCN Am J Matern Child Nurs 28 (2003), 252–257 quiz 58-9.
46. Shander, A., Isbister, J., Gombotz, H., Patient blood management: the global view. Transfusion 56 (2016), S94–S102.
47. Welch, H.G., Meehan, K.R., Goodnough, L.T., Prudent strategies for elective red blood cell transfusion. Ann Intern Med 116 (1992), 393–402.
48. Goodnough, L.T., Bravo, J.R., Hsueh, Y.S., Keating, L.J., Brittenham, G.M., Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion. Transfusion 29 (1989), 821–822.
49. Goodnough, L.T., Levy, J.H., Murphy, M.F., Concepts of blood transfusion in adults. Lancet 381 (2013), 1845–1854.
50. Goodnough, L.T., Nemeth, E., Ganz, T., Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116 (2010), 4754–4761.
51. Tolkien, Z., Stecher, L., Mander, A.P., Pereira, D.I., Powell, J.J., Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One, 10, 2015, e0117383.
52. Camaschella, C., New insights into iron deficiency and iron deficiency anemia. Blood Rev 31 (2017), 225–233.
53. Govindappagari, S., Burwick, R.M., Treatment of iron deficiency anemia in pregnancy with intravenous vs oral iron: systematic review and meta-analysis. Am J Perinatol 36 (2019), 366–376.
54. Seid, M., Rogers, R., Dinh, Q., Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study. Am J Obstet Gynecol, 197, 2007, S26.
55. Westad, S., Backe, B., Salvesen, K., Nakling, J., Okland, I., Borthen, I., A 12-week randomised, multi-centre study comparing intravenous iron sucrose vs oral ferrous sulphate for treatment of postpartum anaemia. Int J Gynaecol Obstet, 107, 2009, S377.
56. Agrawal, S., Is intravenous iron sucrose an alternative to the oral iron-folate supplementation for treating iron deficiency anemia in pregnant and post natal women?. Int J Gynecol Obstet 119 (2012), S268–S269.
57. Amrita, C., Neha, S., Veena, G., Beenu, A prospective study comparing the efficacy of oral iron, intra-venous iron sucrose and ferric-carboxy-maltose in postpartum anemia. Int J Med Res Health Sci 5 (2016), 107–111.
58. Holm, C., Thomsen, L., Norgaard, A., Langhoff-Roos, J., Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial. Trials, 16, 2015, 5.
59. Jatoth, P., Coundjidapadam, C.S., Intravenous vs oral iron therapy for postpartum anaemia. Br J Obstet Gynaecol, 114, 2007, 655.
60. Urato, A.C., Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol, 112, 2008, 703.
61. Holm, C., Thomsen, L., Norgaard, A., Langhoff-Roos, J., Intravenous iron isomaltoside 1000 (monofer) administered by a high single-dose infusion or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: a randomized controlled trial. Int J Gynecol Obstet, 131, 2015, E118.
62. Khalafallah, A., Dennis, A., Ogden, K., et al. Three-year follow-up of a randomised clinical trial of intravenous vs oral iron for anaemia in pregnancy. BMJ Open, 2, 2012, 5.
63. Razzaq, M., Azam, M.I., Naeem, M.F., Comparison between intravenous iron and oral iron therapy in cases of postpartum anemia. Pak J Med Health Sci 11 (2017), 277–280.
64. Vijayalakshmi, S., Mahendra, G., Pukale, R.S., Linthoingambi, R., Intravenous iron vs oral iron therapy in postpartum anaemia in rural india. J Evol Med Dental Sci 4 (2015), 1666–1671.
65. Holm, C., Intravenous iron treatment after postpartum haemorrhage. Transfus Med, 26, 2016, 23.
66. Kaur, P., Kaur, G., Bhatia, R., Singh, J., Aggarwal, T., Kaur, P., To study the comparison of oral iron vs parenteral iron sucrose in the treatment of postpartum anaemia. J Evol Med Dental Sci 6 (2017), 5337–5339.
67. Dede, A., Uygur, D., Yilmaz, B., Mungan, T., Ugur, M., Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. Int J Gynaecol Obstet 90 (2005), 238–239.
68. Pradhan, S., Patel, O., Raju, M.D., Dash, P., Study of oral vs intravenous iron therapy in postpartum anaemic women. J Evol Med Dental Sci 6 (2017), 4101–4106.
69. Froessler, B., Cocchiaro, C., Saadat-Gilani, K., Hodyl, N., Dekker, G., Intravenous iron sucrose vs oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fetal Neonatal Med 26 (2013), 654–659.
70. Iyoke, C.A., Emegoakor, F.C., Ezugwu, E.C., et al. Effect of treatment with single total-dose intravenous iron vs daily oral iron(III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia. Ther Clin Risk Manag 13 (2017), 647–653.